Order

PharmaConcept is a company to devoted food supplements for people with omega-3 fatty acid deficiency and memory loss.

Dhalifort is a highly concentrated omega-3 fatty acid specially addressed to people with memory problems, such as elderly people with memory loss, memory loss due to polyunsaturated fatty acid deficit, people with Alzheimer’s disease, senile dementia, stress, etc. Other people with memory problems associated with different pathophysiological situations may also benefit from Dhalifort.

Dhalifort contains over 95% of omega-3 fatty acids and over 80% of the brain- protecting fatty acid DHA. Heatlh authorities have recommended DHA for maintenance and improvement of brain functions.

Why Dhalifort is better than other DHA-based products for the treatments of cognitive decline?
First of all, DHA content in Dhalifort is higher than most food supplements found on the market. On the other hand, the main component of Dhalifort is (DHA-H). Scientific studies demonstrate that the DHA- H form is more efficacious to stop neurodegeneration and improve the cognitive score.

Product name Price Quantity (pcs) Total
DHALifort 30 Capsules 290.00 €
0

Personal data

Billing information

Shipping information

Payment method

PharmaConcept Kft EUR account number
KDB Bank
IBAN: HU96 13576592-13102010-00009397
SWIFT code: KODBHUHB

Shipping and handling

Shipping and Insurance Pricelist
Fedex Economy
Fedex Priority
Coreos
Fedex Economy with insurance
Fedex Priority with insurance
Product name Price Quantity (pcs) Total
DHALifort 30 Capsules 290.00 € 0 0
Shipping and handling 0 0
Insurance 0 0
0

Referencies

Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimers disease

/ Pablo V. Escribá /

The unfolded protein response in the therapeutic effect of hydroxy-dha against alzheimer’s disease. The present results in part explain the pharmacological effects of HDHA inducing full recovery of the cognitive scores in murine models of AD.

/ Pablo V. Escribá /

Efficacy and mechanism of action of novel synthetic fatty acids derivatives in a transgenic drosophila melanogaster model of alzheimer’s disease

/ Pablo V. Escribá /

Next Previous